|
On Thursday, Jan. 11, the Center for International Business
and the Health Care Club at the Tuck
School of Business will host a conference on globalization and the
pharmaceutical and biotechnology ("biopharma") industries. The conference
will begin at noon in the Cohen Great Hall at Tuck with a keynote luncheon.
Peter R. Dolan, Tuck '80, former chairman and CEO of Bristol-Myers Squibb, will
deliver the keynote address, "The Effects of Globalization on the
Biopharma Industry."
Biopharma companies increasingly are searching the world both for new
markets and for opportunities to reduce drug development costs, efforts that
are likely to interact with pricing strategies, sourcing decisions, and company
structure. The conference will address questions including:
- How sustainable are payment systems that can vary dramatically by
country?
- How will changes in those payment systems going forward affect companies
and customers?
- How can companies leverage emerging countries to reduce drug development
costs?
- Is the biopharma industry headed for a truly global model of development
and production?
The keynote luncheon will be followed by two panel discussions. The first,
"The Challenges of Drug Pricing in Global Markets," will be held at
1:30 p.m. in the Shapiro classroom at Tuck. Panelists include David Meeker,
president of lysosomal disorder therapeutics at Genzyme, and John Cullity,
senior director of strategic pricing at Sanofi-Aventis. The panel,
"Opportunities to Reduce Drug Costs in a Global Economy," will be
held after a short break in the same location.
Panelists include: Kenneth Kaitin, director of the Center for the Study of
Drug Development, Tufts University; Anne Sullivan, Tuck '95, senior director of
business development, Sepracor; and Anil Khurana, director of operations
strategy and private equity, PRTM. Stephen Spielberg, dean of Dartmouth Medical School, will
moderate.
The conference is free and open to the public. For more information or to
register, visit www.tuckhealthcare.com or call
646-9306.
By LISA MILLER
|
RSS/XML Feed